Nucala 100 mg/mL, Injektionslösung im Fertigpen

7680673500019 CH-67350 Injektionslösung im Fertigpen
Nucala 100 mg/mL, Injektionslösung im Fertigpen
Nucala 100 mg/mL, Injektionslösung im Fertigpen
Nucala 100 mg/mL, Injektionslösung im Fertigpen
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Injektor(en), vorgefüllt/Pen
Galenic form
Injektionslösung im Fertigpen
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
02/03/2026
Patient information leaflet
Français
02/03/2026
Patient information leaflet
Italien
02/03/2026
Summary of Product Characteristics
Allemand
02/03/2026
Summary of Product Characteristics
Français
02/03/2026
Summary of Product Characteristics
Italien
02/03/2026

Detailed composition

Substance Quantity Type Category
mepolizumabum
100.0 MG Substance Wirkstoff (Principe actif)
saccharum
- Substance HNIDK
dinatrii phosphas heptahydricus
- Substance HNIDK
acidum citricum monohydricum
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
dinatrii edetas
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
0.72 MG Substance HBESI

Reimbursement information

Public price
CHF 1014.15
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/04/2020

Authorization holder

GlaxoSmithKline AG

6340 Baar

Authorization information

Swissmedic authorization number
67350
Drug name
Nucala, Injektionslösung im Fertigpen
Galenic form
INLFP
ATC Code
R03DX09
Authorization status
Z
Dispensing category
B
First authorization
13/02/2020
Authorization expiration date
31/12/9999
IT Number
03.04.5.
Domain
Human medicine
Field of application
Eosinophiles Asthma, EGPA, CRSwNP, HES, COPD

Package details

Description (FR)
NUCALA sol inj 100 mg/ml stylo prérempli
Description (DE)
NUCALA Inj Lös 100 mg/ml Fertigpen
Market launch
13/02/2020
Narcotic (BTM)
No

Other package sizes (1)

NUCALA sol inj 100 mg/ml stylo prérempli 3 pce
3 x 1 STU
GTIN: 7680673500026
View
Buy us a coffee Explore the data